Myocyte Enhancer Factor 2C as a New Player in Human Breast Cancer Brain Metastases
Open Access
- 12 February 2021
- Vol. 10 (2), 378
- https://doi.org/10.3390/cells10020378
Abstract
Myocyte enhancer factor 2C (MEF2C) is increasingly expressed in mice along with breast cancer brain metastases (BCBM) development. We aim to ascertain MEF2C expression in human BCBM, establish the relationship with disease severity, disclose the involvement of vascular endothelial growth factor receptor-2 (VEGFR-2) and β-catenin, also known as KDR and CTNNB1, respectively, and investigate if matched primary tumors express the protein. We studied resected BCBM for the expression of MEF2C, VEGFR-2, and ß-catenin, as well as proliferation (Ki-67) and epithelial (pan Cytokeratin) markers, and related experimental and clinical data. MEF2C expression was further assessed in matched primary tumors and non-BCBM samples used as controls. MEF2C expression was observed in BCBM, but not in controls, and was categorized into three phenotypes (P): P1, with extranuclear location; P2, with extranuclear and nuclear staining, and P3, with nuclear location. Nuclear translocation increased with metastases extension and Ki-67-positive cells number. P1 was associated with higher VEFGR-2 plasma membrane immunoreactivity, whereas P2 and P3 were accompanied by protein dislocation. P1 was accompanied by β-catenin membrane expression, while P2 and P3 exhibited β-catenin nuclear translocation. Primary BC samples expressed MEF2C in mammary ducts and scattered cells in the parenchyma. MEF2C emerges as a player in BCBM associated with disease severity and VEGFR-2 and β-catenin signaling.Funding Information
- Fundação para a Ciência e a Tecnologia (PTDC/MED-ONC/29402/2017, UIDB/04138/2020 and UIDP/04138/2020.)
This publication has 38 references indexed in Scilit:
- Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanismMolecular Cancer, 2014
- Breast cancer as a systemic disease: a view of metastasisJournal of Internal Medicine, 2013
- Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancerCancer and Metastasis Reviews, 2012
- Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cellsMolecular Cancer, 2011
- The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastasesCancer, 2010
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancerCancer, 2008
- Vascular Endothelial Growth Factor Induces MEF2C and MEF2-Dependent Activity in Endothelial CellsInvestigative Ophthalmology & Visual Science, 2008
- Breast Tumor Kinase (Protein Tyrosine Kinase 6) Regulates Heregulin-Induced Activation of ERK5 and p38 MAP Kinases in Breast Cancer CellsCancer Research, 2007
- Progression-Specific Genes Identified by Expression Profiling of Matched Ductal Carcinomas In situ and Invasive Breast Tumors, Combining Laser Capture Microdissection and Oligonucleotide Microarray AnalysisCancer Research, 2006
- Cooperating cancer-gene identification through oncogenic-retrovirus–induced insertional mutagenesisBlood, 2005